Table 1 Performance (area under the receiver-operating curve (AUC), sensitivity, specificity, positive and negative predictive values, and likelihood ratio) of each candidate markers dichotomized into lower than, higher, or equal to the cutpoint distinguishing ICU and non-ICU COVID-19 patients of the discovery cohort.

From: The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients

Marker

Cutpoint

AUC

Sensitivity

Specificity

Positive predictive value

Negative predictive value

Likelihood ratio

HGF

593.1

0.911 (0.854–0.969)

88.6 (75.4–96.2)

81.5 (68.6–90.7)

79.6 (65.7–89.8)

98.9 (98.6–99.2)

4.79 (2.71–8.46)

CXCL13

119.7

0.875 (0.801–0.948)

88.6 (75.4–96.2)

79.6 (66.5–89.4)

78.0 (64.0–88.5)

89.6 (77.3–96.5)

4.35 (2.54–7.45)

CXCL9

19

0.869 (0.801–0.936)

84.1 (69.9–93.4)

74.1 (60.3–85.0)

72.5 (58.3–84.1)

85.1 (71.7–93.8)

3.24 (2.03–5.18)

IL-6

25.6

0.796 (0.708–0.884)

77.3 (62.2–88.5)

79.6 (66.5–89.4)

75.6 (60.5–87.1)

81.1 (68.0–90.6)

3.79 (2.19–6.58)

CCL2

121.3

0.775 (0.676–0.873)

65.9 (50.1–79.5)

85.2 (72.9–93.4)

78.4 (61.8–90.2)

75.4 (62.7–85.5)

4.45 (2.27–8.73)

CXCL10

156

0.743 (0.640–0.846)

68.2 (52.4–81.4)

75.9 (62.4–86.5)

69.8 (53.9–82.8)

74.5 (61.0–85.3)

2.83 (1.69–4.74)

IL-1RA

2741.7

0.734 (0.635–0.833)

79.5 (64.7–90.2)

61.1 (46.9–74.1)

62.5 (48.5–75.1)

78.6 (63.2–89.7)

2.05 (1.42–2.95)

CCL4

40

0.714 (0.611–0.818)

79.5 (64.7–90.2)

59.3 (45.0–72.4)

61.4 (47.6–74.0)

78.0 (62.4–89.4)

1.95 (1.37–2.78)

VEGF-A

677.4

0.702 (0.597–0.807)

61.4 (45.5–75.6)

77.8 (64.4–88.0)

69.2 (52.4–83.0)

71.2 (57.9–82.2)

2.76 (1.59–4.79)

IL-15

16.2

0.689 (0.581–0.796)

65.9 (50.1–79.5)

72.2 (58.4–83.5)

65.9 (50.1–79.5)

72.2 (58.4–83.5)

2.37 (1.47–3.83)

IL-10

3.1

0.687 (0.599–0.775)

50.0 (34.6–65.4)

88.9 (77.4–95.8)

78.6 (59.0–91.7)

68.6 (56.4–79.1)

4.50 (2.00–10.1)

IL-1β

4.325

0.690 (0.582–0.797)

69.8 (53.9–82.8)

70.9 (57.1–82.4)

65.2 (49.8–78.6)

75 (61.1–86.0)

2.4 (1.5–3.8)

LIF

15.23

0.703 (0.597–0.809)

65.1 (49.1–79.0)

72.7 (59.0–83.9)

65.1 (49.1–79.0)

72.7 (59.0–83.9)

2.4 (1.5–3.9)